Position in ABBV
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$6,883,863
+$2,324,838 QoQ
Shares Held
27,356
+30.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.70%
of 13F equity value
Holder Rank
#1,122
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NWAM LLC holds $48,579,826 across 13 Drug Manufacturers - General names. ABBV ranks #2 (14.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
15,632 | $18,749,491 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
27,356 | $6,883,863 | |
| 3 | JNJ |
Johnson & Johnson
|
25,030 | $6,356,869 | |
| 4 | AMGN |
Amgen Inc
|
16,081 | $5,823,251 | |
| 5 | MRK |
Merck & Co., Inc.
|
20,971 | $2,694,773 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
13,024 | $1,645,452 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
24,139 | $1,390,889 | |
| 8 | PFE |
Pfizer Inc
|
51,769 | $1,246,597 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,883,863 | 27,356 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $4,559,025 | 20,962 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $4,747,793 | 20,779 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $4,829,692 | 20,859 | Shares | Sole | 2026-02-04 | |
| 2025-06-30 | $3,990,830 | 21,500 | Shares | Sole | 2026-02-04 | |
| 2025-03-31 | $4,269,598 | 20,378 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $3,686,564 | 20,746 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $4,004,894 | 20,280 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,643,980 | 15,415 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $1,824,277 | 10,018 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $2,314,786 | 14,937 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,257,662 | 15,146 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $2,031,324 | 15,077 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,392,893 | 8,740 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,448,391 | 15,150 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $2,133,536 | 15,897 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,324,815 | 15,179 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $2,738,362 | 16,892 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $2,146,090 | 15,850 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,424,207 | 13,203 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $1,469,050 | 13,042 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $1,526,984 | 14,110 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $1,331,874 | 12,430 | Shares | Sole | 2021-01-22 | |
| 2020-09-30 | $1,199,194 | 13,691 | Shares | Sole | 2020-10-16 | |
| 2020-06-30 | $4,093,713 | 41,696 | Shares | Sole | 2020-07-21 | |
| 2020-03-31 | $1,569,209 | 20,596 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||